Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Liperoti

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Evidence-Based Mental Health|April 28, 2009
Starting a conventional antipsychotic increases risk of death more than an atypical antipsychotic in elderly people with dementiaRosa Liperoti
Evidence-Based Mental Health|April 28, 2006
Review: atypical antipsychotic drugs slightly increase mortality rates in elderly people with dementiaRosa Liperoti
The Lancet. Healthy Longevity|June 16, 2026
Antipsychotics in dementia: the road to deprescribingRosa Liperoti, Graziano Onder
JAMA|March 9, 2016
JAMA PATIENT PAGE. Herbal MedicationsGraziano Onder, Rosa Liperoti
BMJ (Clinical Research Ed.)|September 23, 2010
Antipsychotics and the risk of venous thromboembolismRosa Liperoti, Giovanni Gambassi
Journal of the American Medical Directors Association|February 19, 2013
The management of behavioral and psychological symptoms of dementia: the need for tailored interventionsRosa Liperoti, Francesco Landi
Current Neuropharmacology|March 24, 2009
Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD)Rosa Liperoti, Claudio Pedone, Andrea Corsonello
European Journal of Nutrition|July 3, 2013
The usefulness of anthropometric measuresFrancesco Landi, Rosa Liperoti, Graziano Onder
Journal of the American Medical Directors Association|June 29, 2011
Postacute rehabilitation in cognitively impaired patients: comprehensive assessment and tailored interventionsFrancesco Landi, Rosa Liperoti, Roberto Bernabei
The Journal of Clinical Psychiatry|October 13, 2015
Managing antipsychotic medications in schizophrenia: comprehensive assessment and personalized care to improve clinical outcomes and reduce costsRosa Liperoti, Roberto Bernabei, Graziano Onder
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Evidence-Based Mental Health|April 28, 2009
Starting a conventional antipsychotic increases risk of death more than an atypical antipsychotic in elderly people with dementiaRosa Liperoti
Evidence-Based Mental Health|April 28, 2006
Review: atypical antipsychotic drugs slightly increase mortality rates in elderly people with dementiaRosa Liperoti
The Lancet. Healthy Longevity|June 16, 2026
Antipsychotics in dementia: the road to deprescribingRosa Liperoti, Graziano Onder
JAMA|March 9, 2016
JAMA PATIENT PAGE. Herbal MedicationsGraziano Onder, Rosa Liperoti
BMJ (Clinical Research Ed.)|September 23, 2010
Antipsychotics and the risk of venous thromboembolismRosa Liperoti, Giovanni Gambassi
Journal of the American Medical Directors Association|February 19, 2013
The management of behavioral and psychological symptoms of dementia: the need for tailored interventionsRosa Liperoti, Francesco Landi
Current Neuropharmacology|March 24, 2009
Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD)Rosa Liperoti, Claudio Pedone, Andrea Corsonello
European Journal of Nutrition|July 3, 2013
The usefulness of anthropometric measuresFrancesco Landi, Rosa Liperoti, Graziano Onder
Journal of the American Medical Directors Association|June 29, 2011
Postacute rehabilitation in cognitively impaired patients: comprehensive assessment and tailored interventionsFrancesco Landi, Rosa Liperoti, Roberto Bernabei
The Journal of Clinical Psychiatry|October 13, 2015
Managing antipsychotic medications in schizophrenia: comprehensive assessment and personalized care to improve clinical outcomes and reduce costsRosa Liperoti, Roberto Bernabei, Graziano Onder
Pageof 11